What did EBOS Group Limited announce?
EBOS Group Limited (NZX: EBO) filed “Capital Change Notices” with NZX on 12 October 2026, as a capital change announcement.
- Which company?
- EBOS Group Limited (NZX: EBO)
- When was it filed?
- 12 October 2026
- Where is the original?
- NZX announcement
Capital Change Notices
Capital Change Notice
Section 1: Issuer information
Name of issuer EBOS Group Limited
NZX ticker code EBO
Class of financial product Options to acquire fully paid ordinary shares
(Shares) (with each Option granting the
holder the right to acquire one Share as
described below) pursuant to the EBOS
Group Limited Equity Plan (Plan).
ISIN (If unknown, check on NZX website) Not applicable – Options will not be listed on
NZX or ASX.
Currency AUD.
Section 2: Capital change details
Number issued 1,030,520 Options
Nominal value (if any) Not applicable.
Issue price per security Options were issued for nil consideration.
Exercise Price of A$16.55, which is payable
on exercise of the relevant underlying
Options.
Nature of the payment (for example, cash or
other consideration)
To exercise the Options, cash consideration
of A$16.55 is payable on the exercise of the
relevant underlying Options.
The Option holder may request that EBOS
Group Limited (the Company) allows the
relevant Options to be exercised on a
cashless basis. If the Company agrees to the
request:
the aggregate number of Shares that
would otherwise be issued or transferred
to the Option holder in connection with
the exercise of the Options will be
reduced by the aggregate Exercise Price
in respect of the Options divided by the
market value of an ordinary share as at
the date of exercise of the Options
(rounded down to the nearest whole
number of Shares); and
the Exercise Price will be varied to nil
such that the Option holder will not be
required to pay any Exercise Price in
connection with the exercise of the
Options.
Amount paid up (if not in full) Not applicable.
Percentage of total class of Financial Products
issued (calculated on the number of Financial
100% of Options.
Products of the Class, excluding any Treasury
Stock, in existence)
For an issue of Convertible Financial Products
or Options, the principal terms of Conversion
(for example the Conversion price and
Conversion date and the ranking of the
Financial Product in relation to other Classes of
Financial Product) or the Option (for example,
the exercise price and exercise date)
Vesting of the Options is generally subject to
the Option holder remaining employed on the
date that the Option holder is notified of the
outcome of the testing of the vesting
conditions for the performance rights issued
to the Option holder for the period 1 July
2026 to 30 June 2029. Subject to applicable
law, the Board has discretion to allow Options
to vest notwithstanding cessation of
employment before such date, for example in
'good leaver' circumstances.
The Exercise Price is described above.
The expiry date of the Options is 5 October
2036.
For each Option that vests the Option holder
will be entitled to one Share in the Company
or an equivalent amount in cash or a
combination of both (as determined by the
Board). Any Shares issued following vesting
will rank equally with existing fully paid
ordinary shares. If the Option is to be
satisfied with Shares, the Option holder may
request that the Options are exercised on a
cashless basis (as described above).
The Options have no dividend entitlement
prior to exercise.
Reason for issue and specific authority for issue
(the reason for change must be identified here)
Grant of Options under the Plan.
Total number of Financial Products of the Class
after the issue (excluding Treasury Stock) and
the total number of Financial Products of the
Class held as Treasury Stock after the issue.
100% of Options
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
Not applicable.
Specific authority for the issue including a
reference to the rule pursuant to which the issue
is made
Directors’ resolution in accordance with NZX
Listing Rule 4.6.1.
Terms or details of the issue (for example:
restrictions, escrow arrangements)
Please see above.
Date of issue 12 October 2026
Section 3: Authority for this announcement and contact person
Name of person
authorised to make this
announcement
Janelle Cain
Capital Change Notice
Contact person for this announcement Janelle Cain
Contact phone number +61 3 9918 5555
Contact email address janelle.cain@ebosgroup.com
Date of release through MAP
12 October 2026
---
Capital Change Notice
Section 1: Issuer information
Name of issuer EBOS Group Limited
NZX ticker code EBO
Class of financial product Performance Rights representing an
entitlement to fully paid ordinary shares
(Shares) pursuant to the EBOS Group
Limited Equity Plan (Plan).
ISIN (If unknown, check on NZX website) Not applicable – the Performance Rights will
not be listed on NZX or ASX.
Currency Not applicable.
Section 2: Capital change details
Number issued 690,456 Performance Rights
Nominal value (if any) Not applicable.
Issue price per security Not applicable.
Nature of the payment (for example, cash or
other consideration)
Not applicable.
Amount paid up (if not in full) Not applicable.
Percentage of total class of Financial Products
issued (calculated on the number of Financial
Products of the Class, excluding any Treasury
Stock, in existence)
69.79% of Performance Rights on issue.
For an issue of Convertible Financial Products
or Options, the principal terms of Conversion
(for example the Conversion price and
Conversion date and the ranking of the
Financial Product in relation to other Classes of
Financial Product) or the Option (for example,
the exercise price and exercise date)
Vesting of the Performance Rights is subject
to the satisfaction of certain conditions
relating to EBOS Group Limited (the
Company) financial performance and/or the
continued employment of the holder of the
Performance Rights (Performance
Conditions). Subject to applicable law, the
Board has discretion to allow Performance
Rights to vest notwithstanding cessation of
employment before the vesting date, for
example in 'good leaver' circumstances.
The Performance Conditions will be tested
after the end of the performance period,
being 1 July 2026 to 30 June 2029.
For each Performance Right that vests the
holder will be entitled to one Share in the
Company or an equivalent amount in cash or
a combination of both (as determined by the
Board). Any Shares issued following vesting
will rank equally with existing fully paid
ordinary shares.
The Performance Rights have no dividend
entitlement prior to vesting.
There is no amount payable by the
Performance Rights holders either on grant
or exercise of the Performance Rights.
Reason for issue and specific authority for issue
(the reason for change must be identified here)
Issue of Performance Rights under the Plan.
Total number of Financial Products of the Class
after the issue (excluding Treasury Stock) and
the total number of Financial Products of the
Class held as Treasury Stock after the issue.
1,679,722 Performance Rights.
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
Not applicable.
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
Directors’ resolution.
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
Please see above.
Date of issue 12 October 2026
Section 3: Authority for this announcement and contact person
Name of person
authorised to make this
announcement
Janelle Cain
Contact person for this announcement Janelle Cain
Contact phone number +61 3 9918 5555
Contact email address janelle.cain@ebosgroup.com
Date of release through MAP
12 October 2026
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- PEB — Pacific Edge Limited: Capital Change Notice - Issue of Options2026-09-14
“Capital Change Notice Updated as at February 2025 Section 1: Issuer information Name of issuer Pacific Edge Limited NZX ticker code PEB Class of financial product Options to acquire ordinary shares (with each option granting the holder the right to acquire one ordin…”
- PEB — Pacific Edge Limited: Capital Change Notice - Exercise of Options2026-10-01
“Capital Change Notice Updated as at February 2025 Section 1: Issuer information Name of issuer Pacific Edge Limited NZX ticker code PEB Class of financial product Options to acquire Ordinary Shares – Conversion to Ordinary Shares ISIN (If unknown, check on NZX websi…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice - Issue of Options2026-09-09
“Capital Change Notice 9 September 2026 Issue of Options This notice is given under NZX Listing Rule 3.13.1 and relates to unlisted Options to acquire ordinary shares in the Company (‘Options’) issued under the Fisher & Paykel Healthcare 2025 Share Option Plan (‘Option P…”